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Background: Phenotypic data are routinely used to elucidate gene function in organisms amenable to genetic
manipulation. However, previous to this work, there was no generalizable system in place for the structured storage
and retrieval of phenotypic information for bacteria.
Results: The Ontology of Microbial Phenotypes (OMP) has been created to standardize the capture of such
phenotypic information from microbes. OMP has been built on the foundations of the Basic Formal Ontology and
the Phenotype and Trait Ontology. Terms have logical definitions that can facilitate computational searching of
phenotypes and their associated genes. OMP can be accessed via a wiki page as well as downloaded from
SourceForge. Initial annotations with OMP are being made for Escherichia coli using a wiki-based annotation capture
system. New OMP terms are being concurrently developed as annotation proceeds.
Conclusions: We anticipate that diverse groups studying microbial genetics and associated phenotypes will
employ OMP for standardizing microbial phenotype annotation, much as the Gene Ontology has standardized
gene product annotation. The resulting OMP resource and associated annotations will facilitate prediction of
phenotypes for unknown genes and result in new experimental characterization of phenotypes and functions.
Keywords: Annotation capture, Bacterial phenotype, Biological ontologies, Controlled vocabulary, Escherichia coli,
Microbial genetics, Phenotype annotation, Phenotypic evidence, WikiBackground
Phenotypes are the observable characteristics of an or-
ganism that result from the expression of a particular
genotype in a particular environment. Traditionally, phe-
notypes and genotypes were linked together by studying
a mutant phenotype of interest followed by genetic map-
ping and characterization to identify the genetic change
that is responsible for the phenotype, a process known
as forward genetics. Recently, high-throughput reverse
genetics methods are increasingly being applied to observe
phenotypic effects of targeted changes to genotypes with
gene knockouts [1] or changes to gene expression patterns
with methods like RNA interference [2]. Such studies have
identified thousands of phenotype-genotype associations.
Until recently, microbial phenotypic information has
been largely captured as free text descriptions in primary
research papers, review articles, and compilations such
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unless otherwise stated.Microbiology [3]. Unfortunately, ambiguities in natural
language confound attempts to retrieve similar informa-
tion across data sources. For example, “serotype” or “sero-
var” both refer to the same phenotypic trait, but a simple
text-based computer query with either word alone would
miss the other. Likewise, one term can be ambiguous:
“sporulation” can be used to describe the general process
of spore formation, but it is usually used to refer to a more
precise concept such as sporulation to survive adverse
conditions (such as endospore formation in Bacillus) or
sporulation for the purpose of reproduction (such as
found in Actinomyces). A search just for “sporulation”
could return imprecise results. Issues such as these ham-
per the ability to integrate different phenotypic data sets
for the same organism or to leverage known phenotypic
information in one strain/species to predict possible phe-
notypes in other strains/species. Ideally, phenotype infor-
mation should be stored in a consistent, computable
format for ease of data integration and mining.
Controlled vocabularies, including ontologies, are com-
monly used to provide both consistent terminology and aal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Chibucos et al. BMC Microbiology  (2014) 14:294 Page 2 of 8structured data format for the capture of biological infor-
mation [4]. An ontology consists of a controlled vocabu-
lary of defined terms with unique identifiers and precise
relationships to each other. In such a system, synonymous
concepts are all encapsulated (as synonyms) within a pri-
mary term with a single identifier. In cases where the same
word refers to multiple concepts, each concept is made
into a separate term with a unique identifier and a defin-
ition that provides information on the precise meaning,
and each term is placed in an appropriate area of the
ontology in relation to other terms. When using an on-
tology for capturing phenotype information, terms des-
cribing each phenotype are linked to particular genotypes
through the process of annotation. Thus, effective query
and comparison of phenotype data across multiple data-
sets, organisms, and strains can be accomplished. Such a
dataset could have major applications in functional phe-
nomics, the elucidation of gene function from phenotypes
(Figure 1). Uncharacterized genes could be linked to genes
that are associated with known phenotypes using a num-
ber of bioinformatics approaches including orthology, ge-
nomic context (such as operons), co-expression, and
protein-protein interactions [5-7]. This would provide a
set of predicted phenotypes for the uncharacterized
genes that can be tested. A second application for such
a dataset would be that of strain variant analysis. In-
creasingly, multiple strains of one species (up to several
hundred or thousand) are being sequenced. These strains
often vary significantly in both gene content and pheno-
typic characteristics, including for example host range,
antibiotic resistance profiles, and virulence. The ability to
correlate differences in gene content with phenotypic dif-
ferences could help target genes likely to be involved inFigure 1 Using a phenotype ontology to elucidate gene function.these processes and advance research into infectious dis-
ease and human health [8].
Currently, there are anatomy and phenotype ontologies
in common use for many multicellular organisms inclu-
ding mouse [9], Drosophila [10], Caenorhabditis elegans
[11], zebrafish [12], and plants [13], enabling improved
analysis of phenotype data. Similar efforts for microbes in-
clude ontologies for Schizosaccharomyces pombe [14] and
Ascomycetes [15]. However, none of the existing ontol-
ogies is appropriate to comprehensively capture pheno-
types for Bacteria or Archaea or for enabling comparisons
across microbial species. Here we describe the deve-
lopment of a general Ontology of Microbial Phenotypes
(OMP). Initial term development efforts have been fo-
cused on bacterial phenotypes. However, future OMP
development will expand the scope to include Archaea
and eventually all microbes. OMP can be accessed via a
wiki-based ontology browser [16] and from the Source-
Forge development site [17].
Implementation
OMP structure and organization
OMP is a general microbial phenotype ontology appli-
cable to diverse microbes. Microbial phenotypes include
properties of single organisms as well as populations of
cells, such as colonies, biofilms, pellicles, and liquid cul-
tures. Entities described by OMP include phenotypes that
are directly observed and phenotypes that are inferred
from indirect evidence. Examples of directly observed
phenotypes are cell and colony morphologies and the
presence or absence of motility. Inferred phenotypes in-
clude most physiological phenotypes. For example, while
it is technically possible to observe utilization of a sugar
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to infer that utilization is present or absent based on the
ability or inability of the sugar to support growth or trans-
form indicator dyes.
Furthermore, there are two distinct classes of pheno-
types: independent phenotypes that provide information
about an organism without reference to any other infor-
mation and dependent phenotypes that capture a relative
difference observed when comparing (at least) two se-
parate genotypes or conditions. To illustrate the diffe-
rence between independent and dependent phenotypes
consider the phenotypes associated with motility. If a
strain of E. coli were observed to move, it would have
the independent phenotype “presence of cell motility”.
However, if a mutation in a particular E. coli strain led
to a reduction of motility, then that strain would be de-
scribed by the dependent phenotype “decreased cell mo-
tility,” which is relative to the strain used as a reference.
Organisms that are non-motile, such as Klebsiella pneu-
monia, would have the independent phenotype “absence
of cell motility” [3]. Terms for both independent and de-
pendent phenotypes are essential to represent the rich-
ness of genetics and genetic interactions (for examples,
see [18-22]). OMP and its associated annotation sys-
tem have been designed to capture all of these typesFigure 2 Ontology of Microbial Phenotypes (OMP) in the context of B
(PATO), and Gene Ontology (GO). Terms from respective ontologies are
OMP, purple. (Note that “quality” exists in both BFO and PATO, and PATO
are indicated by solid lines, and relationships inferred by a reasoner are in
participates_in; Q, has_quality.of phenotypes. In the ontology, terms for independent
and dependent phenotypes can be distinguished by
their definitions as well as by the fact that dependent
phenotypes are linked to relevant parent class “altered
phenotype” terms. We have examined the term structures
of related ontologies such as the Fission Yeast Phenotype
Ontology (FYPO) [14] in order to ensure compatibility be-
tween OMP and other resources. We hope to ultimately
develop OMP to be able to represent all phenotypes in
other ontologies related to microbes allowing analysis of
annotations to be linked together into one system.
OMP is built using foundations provided by Basic
Formal Ontology (BFO) [23] and Phenotype and Trait
Ontology (PATO) [24]. BFO provides a framework of
upper level terms to support domain-specific ontology
development. PATO contains phenotypic attributes for
use in developing phenotype terms. Figure 2 shows how
OMP relates to BFO and PATO, using terms related to mo-
tility as an example. All OMP terms (classes) descend from
a root class called “microbial phenotype”. Because mi-
crobial phenotypes describe both processes (e.g. motility)
and objects (e.g. cells), the OMP root class would be a dir-
ect child of the BFO root class “BFO entity.” However, the
more granular (specific) OMP classes also connect to
either the “continuant” or “occurrent” branches of BFOasic Formal Ontology (BFO), Phenotypic Quality Ontology
rendered in different color type: BFO, black; PATO, blue; GO, red; and
instantiates the concept of “process quality”.) Asserted relationships
dicated by dotted lines. Abbreviations: I, is_a; IH, inheres_in; PI,
Chibucos et al. BMC Microbiology  (2014) 14:294 Page 4 of 8[25] by way of external ontologies, such as PATO or
GO, as shown in Figure 2. Continuants are entities that
persist through time, and include both objects, such as
a bacterial cell or colony, and qualities of objects, such
as cell shape or colony color. Occurrents are entities
that have a temporal part and that occur through time,
and include processes that an object can participate in,
for example cell motility. In order to qualify processes
(e.g. “decreased cell motility”), OMP follows the model of
PATO, which defines “process quality” (PATO:0001236)
as “a quality which inheres in a process.”
We have included umbrella terms to group indepen-
dent and dependent phenotype terms that refer to the
same biological concepts (Figure 3). For example, the
terms “presence of cell motility”, “absence of cell motility”,
and “decreased cell motility” are all related to the same
biological concept (cell motility) and are all thus also sub-
classes of “cell motility phenotype”, itself a subclass of
“locomotion phenotype” (Figure 2). “The umbrella term
names end in the word ‘phenotype’ (Figure 3).” These
terms are particularly useful for querying of related an-
notations. We recommend that they not be used directly
in annotations as there will usually be a more specific
child term available. These terms are similar to the
Gene Ontology (GO) grouping terms such as “cell part”,
GO:0044464, which GO guidelines indicate should not be
used for annotation [26,27].
Finally, OMP employs the qualifier “altered_relative_to”
for dependent phenotype terms, which denote a difference
in phenotype between organisms of two different ge-
notypes or the same genotype assessed in two differentFigure 3 Root class and high-level grouping terms of the Ontology oenvironments. We have avoided the use of the qualifier
“abnormal” for two reasons: there can be no consistent
definition of what is “normal” or “abnormal” across organ-
isms, and “altered_relative_to” is superior for capturing
phenotypes of genetic modifiers such as suppressors and
enhancers [28]. An altered phenotype is always relative to
the phenotype of a designated control, which can be speci-
fied in the annotation (see below), or set to an arbitrary
reference within an annotation set (e.g. a wild-type refer-
ence genotype within a species).
Term development
All terms in OMP have genus-differentia definitions,
where a term is a subclass of a parent term and is distin-
guished from other related subclass terms (siblings) by
some differentiating characteristic unique to that term
(and could be phrased as “B is an A that C’s”). For ex-
ample, “cell motility by gliding” (B) is a “presence of cell
motility phenotype” (A) that has the differentia “where a
cell or cells exhibits smooth movement along a solid
surface” (C). Terms also contain synonyms that allow for
more effective keyword searches to be conducted. For
instance, the OMP term “serotype” has synonyms “anti-
genic typing phenotype,” “serological test phenotype,”
and “serovar.”
In addition to standard definitions and synonyms,
many OMP terms contain a cross product, a special type
of logical definition that represents the intersection of
two or more terms [29]. These are based on a specified
genus and a collection of differentiae. OMP cross prod-
ucts are derived by using relationships to connect a termf Microbial Phenotypes.
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ogies. For example, the OMP term “motility phenotype”
is equivalent to the intersection of the OMP root term
“microbial phenotype” (OMP:0000000) and the GO biolo-
gical process term “cell motility” (GO:0048870) using the
OBO Relations Ontology [30] relationship “inheres_in”
(RO:0000052). In OBO syntax, this logical definition is
expressed as:
OMP:0000001
name: cell motility phenotype
is_a: OMP:0000312 ! locomotion phenotype
intersection_of: OMP:0000000 ! microbial phenotype
intersection_of: inheres_in GO:0048870 ! cell motility
intersection_of: inheres_in GO:0005623 ! cell
Cross products are also used in OMP to implement
the entity-quality (E-Q) method of phenotypic character
description. In the E-Q model a bearer entity (e.g. a cell,
cell part, or biological process) is associated with a qual-
ity (e.g. shape, decreased number, or altered duration),
and together these comprise the “phenotype” [31]. OMP
uses entity terms from OMP or other appropriate ontol-
ogies such as the GO along with qualities from PATO.
For example, the term “decreased cell motility” is a type
of “altered cell motility,” with the added quality “decreased
process quality.” In this example, “altered cell motility”
comes from within OMP and “decreased process quality”
comes from PATO. The two terms are joined by the rela-
tionship has_quality (RO:0000086). In OBO syntax, this
logical definition takes the form:
OMP:0000002
name: decreased cell motility
is_a: OMP:0007001 ! altered cell motility
intersection_of: OMP:0007001 ! altered cell motility
intersection_of: has_quality PATO:0002302 ! decreased
process quality
Whenever OMP term logical definitions comprise terms
from external ontologies, OMP policy is to work with
those developers to achieve interoperability.
Most of the existing OMP terms were generated as the
result of OMP working group meetings held at Texas
A&M University (College Station, TX), the Institute for
Genome Sciences (Baltimore, MD), or by conference call.
The term generation process includes examination of texts
such as Bergey's Manual of Determinative Microbiology [3]
and microbial literature, particularly genetic papers and
reviews that are enriched for phenotype information (e.g.
[1,22,32,33]). The process of establishing the structure of
OMP and building the initial term set was carried out over
several months during the beginning stages of the project.
Since then, we have periodically refined the structure, asneeded based on feedback from the community and pro-
ject annotators. Now that annotation using OMP has
begun in earnest (see more information below) we are able
to engage in annotation-driven term development in
which annotators identify phenotypes of interest from
publications and request new terms as needed. This allows
us to ensure that the ontology contains the terms and
structure needed to fully capture real-world information
as it will be encountered by annotators outside of our
group. Ongoing development of OMP is in response to
OMP literature curators, focusing on the genetic litera-
ture of the well-studied model organism, E. coli K-12.
Following the model of the Gene Ontology [26] and
other National Center for Biomedical Ontology onto-
logies [34], OMP is designed to support community par-
ticipation in term development through the use of a
public tracker [35].
OMP is developed in Open Biological Ontologies (OBO)
format syntax with the ontology editor OBO-Edit [36]. A
term tracker [35] is used to manage term requests, which
are researched and added into the ontology. The built-in
OBO-Edit reasoner is run to check term relationships and
validity of cross-product terms.
Results and discussion
Accessing OMP
The first version of OMP was released in June 2011 on
the OMP project’s development site [17], and new ver-
sions are released on a regular basis. Both a developer’s
version and official release versions of OMP can be
viewed at or downloaded from the development site. As
of this writing there are 724 terms in the OMP name
space, of which 100% have definitions. We have also de-
ployed a wiki [16] modeled on Gene Ontology Normal
Usage Tracking System (GONUTS) [37] for exploring
the ontology, and adding usage notes to terms. The pre-
liminary annotations described above are publicly visible
via the OMP wiki. This will be converted to a system for
community contribution of phenotype annotations in
the future. Users wishing to request additions or changes
to OMP may do so using the issue tracker system at our
development site [35].
Use of OMP to capture phenotype annotations
OMP can be used with any user-defined annotation sys-
tem to capture phenotypes in a set of appropriately de-
fined fields containing accessions or free text. OMP could
be used in single-species annotation systems similar to the
ones currently used at Saccharomyces Genome Database
[38] and PomBase [39], where Yeast Phenotype Ontology
and Fission Yeast Phenotype Ontology terms, respectively,
are associated with gene records. However, to fully leve-
rage the design of OMP we are developing an annota-
tion data structure that will provide a more general and
Figure 4 Example annotations of chemotaxis phenotypes reported by Hazelbauer, et al. [40]. A) an independent annotation showing
chemotaxis in the parent strain based on a swimming assay in semisolid medium. B) a dependent annotation for a chemotaxis deficient mutant
characterized by decreased swim diameter in the same soft agar assay. Decreased positive chemotaxis is relative to the genotype/environment
combination specified in the annotation in A.
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pendent phenotypes associated with specific genes and
alleles. A key element of this system will be identifiers
associated with each annotation that will allow dependent
phenotypes to be more fully expressed using relation-
ships between annotations. Figure 4 shows two types of
annotations: Figure 4A depicts an independent phenotype
annotation while Figure 4B shows how a dependent anno-
tation is made relative to the independent annotation in
Figure 4A.
While the more complex annotation system is under
development, we are continuing to collect phenotype in-
formation from publications on E. coli and storing the
following elements: an identifier for the strain or geno-
type being annotated, a description of the environment
or experimental conditions, an OMP term to capture the
phenotype, an Evidence Ontology (ECO) term [7] to cap-
ture the evidence that supports the annotation, and the
reference that was curated to make the annotation. So far
we have associated phenotypes to observations made in
275 papers. These annotations connect OMP term devel-
opment to the corpus of papers used to find examples of
phenotypes that OMP must be able to support. Annota-
tions can be viewed on the OMP wiki.
Conclusions
To facilitate the effective capture and mining of pheno-
typic information for microbes we have undertaken deve-
lopment of an Ontology of Microbial Phenotypes. OMP
consists of a controlled vocabulary and structured lan-
guage where all terms are well-defined representations of
microbial phenotypes. OMP is accessible through a cen-
tralized wiki-based data repository [16] and freely available
for download [17]. Currently, OMP is being used to anno-
tate phenotypes associated with Escherichia coli genes and
strains.The use of OMP with Ec coli will provide a model for
other well-characterized bacterial systems such as Sal-
monella spp., Bacillus subtilis and Caulobacter crescen-
tus. Annotation efforts will produce datasets for general
use in bacterial ‘omic analyses including comparative
and functional phenomics studies, genome annotation,
microbiome studies, and research on infectious disease.
Future work will focus on expansion of these resources
to microbes beyond bacteria. Eukaryotic and prokaryotic
microbes share many phenotypic traits, and we antici-
pate that these can all ultimately be captured in OMP
allowing for even more powerful cross-species data min-
ing and analysis.
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